BridgeBio Pharma Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Welcome, everybody, to (inaudible) Virtual JPMorgan Healthcare Conference. My name is on Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan, I'm joined by Matt Bannon and Tessa Romero for the team. Our next presenting company is BridgeBio. On behalf of company, we have CEO Neil Kumar.
Before I turn it over to Neil, I just wanted to highlight 2 things really quickly that, number one, we are restricted on BridgeBio. And number two, I also wanted to highlight those on the webcast, please submit a question via the ask-the-question portal -- the feature in the portal. Neil, take it away.
Thanks, Anupam. I'll set the timer and refer to the slides as I go through here. And thank you so much to the JPM team for the opportunity to present and to support over the years. I was just talking to Phil Ross this morning about the first time, I spoke with the Anupam and Phil about the BridgeBio hypothesis,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |